Bijuva · DIN 02505223 · 1 mg & 100 mg · capsule
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Bijuva · DIN 02505223
Manufacturer: Knight Therapeutics Inc.; listing date 2024-02-29
Health Canada: Marketed since 2024-01-31 · brand BIJUVA · ATC G03FA04 PROGESTERONE AND ESTROGEN · form Capsule · route Oral · ingredients ESTRADIOL (ESTRADIOL HEMIHYDRATE) 1 MG, PROGESTERONE 100 MG · company Knight therapeutics inc. · schedule Prescription
Bijuva: Formulary list price $0.91 per unit (the source does not state the unit; exact figure $0.9143). What the ministry pays, not the patient.
Ministry pays: $0.9143 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02505223)
Source record
DIN 02505223: Bijuva
Raw flags: sec3=Y
Item: 681600082; group id 736; item number 1804; lccId None; manufacturer id KNT
Source form: Cap; strength: 1mg & 100mg
Recorded listing: General benefit
Source prices (unrounded): $0.9143; ministry $0.9143
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02505223
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99458
Shortage status: not checked (no credentials)